NASDAQ:QTRX
Quanterix Corporation Stock News
$17.88
+1.06 (+6.30%)
At Close: May 15, 2024
Novalis LifeSciences Launches its Second Life Science Investment Fund with $300M and announces key new team members.
04:00pm, Wednesday, 08'th Dec 2021 PR Newswire Asia (English)
HAMPTON, N.H. , Dec. 9, 2021 /PRNewswire/ -- Novalis LifeSciences LLC, an investment and advisory firm for the Life Science industry, announced today that is has raised $300M in capital for its second fund Novalis LifeSciences Investments II, LP. In addition, Paul M. Meister has joined the firm as partner. Novalis LifeSciences is focused on highly innovative Life Science companies. On the occasion of closing the second fund, Marijn E. Dekkers, founder and chairman, said: "This second fund will continue with the investment strategy of Fund I. It will invest in 10-15 companies that are commercializing breakthrough technologies in various segments of the Life Science industry." These segments include biopharma therapeutics, life science tools, genomics, synthetic biology, molecular diagnostics, and agricultural biotechnology all areas with huge unmet needs and exciting opportunities for investors. Some key portfolio companies of Fund I are Ginkgo Bioworks, Cerevel Therapeutics, Decipher Biosciences, Quanterix, and Biotalys, all of which recently became public companies or were acquired.
Quanterix (NASDAQ:QTRX) Sets New 1-Year Low Following Insider Selling
06:22am, Tuesday, 07'th Dec 2021 ETF Daily News
Quanterix Co. (NASDAQ:QTRX) shares reached a new 52-week low on Monday following insider selling activity. The stock traded as low as $35.02 and last traded at $38.64, with a volume of 227545 shares traded. The stock had previously closed at $37.54. Specifically, VP Dawn Mattoon sold 8,535 shares of the companys stock in a transaction [] The post Quanterix (NASDAQ:QTRX) Sets New 1-Year Low Following Insider Selling appeared first on ETF Daily News .
Insider Selling: Quanterix Co. (NASDAQ:QTRX) General Counsel Sells $14,101.50 in Stock
10:54am, Monday, 06'th Dec 2021 Transcript Daily
Quanterix Co. (NASDAQ:QTRX) General Counsel John J. Fry sold 350 shares of the businesss stock in a transaction that occurred on Wednesday, December 1st. The stock was sold at an average price of $40.29, for a total value of $14,101.50. The sale was disclosed in a filing with the SEC, which is available through this []
E Kevin Hrusovsky Sells 3,710 Shares of Quanterix Co. (NASDAQ:QTRX) Stock
10:22pm, Friday, 03'rd Dec 2021 Transcript Daily
Quanterix Co. (NASDAQ:QTRX) CEO E Kevin Hrusovsky sold 3,710 shares of the firms stock in a transaction dated Wednesday, December 1st. The stock was sold at an average price of $40.29, for a total value of $149,475.90. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through []
Critical Review: Quanterix (NASDAQ:QTRX) versus Nautilus Biotechnology (NASDAQ:NAUT)
10:48am, Sunday, 28'th Nov 2021 Dakota Financial News
Quanterix (NASDAQ:QTRX) and Nautilus Biotechnology (NASDAQ:NAUT) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, institutional ownership, earnings, risk, dividends and valuation. Profitability This table compares Quanterix and Nautilus Biotechnologys net margins, return on equity and return on []
Quanterix Co. (NASDAQ:QTRX) Expected to Announce Quarterly Sales of $27.17 Million
07:46am, Friday, 26'th Nov 2021 Transcript Daily
Wall Street brokerages expect Quanterix Co. (NASDAQ:QTRX) to announce sales of $27.17 million for the current fiscal quarter, according to Zacks. Three analysts have made estimates for Quanterixs earnings. The highest sales estimate is $28.18 million and the lowest is $26.10 million. Quanterix posted sales of $26.13 million in the same quarter last year, which []
Given A -110.58% Drop From High, Can Quanterix Corporation (NASDAQ: QTRX) Quickly Recover?
02:00pm, Thursday, 25'th Nov 2021 Marketing Sentinel
During the last session, Quanterix Corporation (NASDAQ:QTRX)s traded shares were 0.41 million, with the beta value of the company hitting 1.44. At the end of the trading day, the stocks price was $43.96, reflecting an intraday gain of 0.80% or $0.35. The 52-week high for the QTRX share is $92.57, that puts it down -110.58 Given A -110.58% Drop From High, Can Quanterix Corporation (NASDAQ: QTRX) Quickly Recover? Read More »
Global Neurological Biomarkers Market Synopsis: By employing an exceptional Neurological Biomarkers Market report, businesses can get details about market drivers and market restraints which help them to take presumption about reducing or growing the production of particular product. When globalization is
Quanterix Recognized as a Fastest-Growing Company in North America on the 2021 Deloitte Technology Fast 500
09:15pm, Wednesday, 17'th Nov 2021 Business Wire
BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis with the goal of advancing the science of precision health, today announced it has been recognized on the Deloitte Technology Fast 500, a ranking of the 500 fastest-growing technology, media, telecommunications, life sciences, fintech, and energy tech companies in North America. This marks the fourth consecutive year Quanterix has been named to the Technology Fast 500. Being recogn
Quanterix (NASDAQ:QTRX) Trading Down 7.6%
06:58pm, Wednesday, 17'th Nov 2021 Dakota Financial News
Quanterix Co. (NASDAQ:QTRX)s stock price fell 7.6% during mid-day trading on Wednesday . The stock traded as low as $49.40 and last traded at $49.65. 4,019 shares were traded during trading, a decline of 99% from the average session volume of 337,831 shares. The stock had previously closed at $53.76. Several brokerages recently issued reports []
Charles Schwab Investment Management Inc. Grows Stock Holdings in Quanterix Co. (NASDAQ:QTRX)
10:08am, Tuesday, 16'th Nov 2021 Dakota Financial News
Charles Schwab Investment Management Inc. increased its stake in shares of Quanterix Co. (NASDAQ:QTRX) by 8.8% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 217,040 shares of the companys stock after buying an additional 17,561 shares during the quarter. Charles Schwab []
AQR Capital Management LLC Acquires 1,194 Shares of Quanterix Co. (NASDAQ:QTRX)
12:08pm, Monday, 15'th Nov 2021 Dakota Financial News
AQR Capital Management LLC grew its holdings in Quanterix Co. (NASDAQ:QTRX) by 5.0% in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 25,248 shares of the companys stock after purchasing an additional 1,194 shares during the quarter. AQR Capital Management LLC owned approximately []
Quanterix Corporation (QTRX) CEO Kevin Hrusovsky on Q3 2021 Results - Earnings Call Transcript
08:33pm, Saturday, 06'th Nov 2021
Quanterix Corporation (QTRX) CEO Kevin Hrusovsky on Q3 2021 Results - Earnings Call Transcript
Quanterix Corporation to Release Third Quarter 2021 Financial Results on Nov. 4, 2021
04:30pm, Thursday, 28'th Oct 2021
BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation to Release Third Quarter 2021 Financial Results on Nov. 4, 2021
Why Shares of Quanterix Are Climbing This Morning
12:09pm, Tuesday, 12'th Oct 2021
Regulators are helping accelerate an early test for Alzheimer's disease.